Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry|January 31, 2006
Bicyclic[4.1.0]heptanes as phenyl replacements for melanin concentrating hormone receptor antagonistsRuo Xu, Shengjian Li, Jaroslava Paruchova, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2012
SAR studies of C2 ethers of 2H-pyrano[2,3-d]pyrimidine-2,4,7(1H,3H)-triones as nicotinic acid receptor (NAR) agonistXianhai Huang, Jing Su, Ashwin U Rao, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a potent thiadiazole class of histamine h3 receptor antagonist for the treatment of diabetesAshwin U Rao, Ning Shao, Robert G Aslanian, et al.
Chemmedchem|July 26, 2017
Development of a New Structural Class of Broadly Acting HCV Non-Nucleoside Inhibitors Leading to the Discovery of MK-8876Casey C McComas, Anandan Palani, Wei Chang, et al.
Journal of Medicinal Chemistry|March 31, 2006
Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo[3.1.0]hexyl ureasMark D McBriar, Henry Guzik, Sherry Shapiro, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2002
HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 useAlexandra Trkola, Shawn E Kuhmann, Julie M Strizki, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and DiabetesAnandan Palani, Andrea R Nawrocki, Federica Orvieto, et al.
Bioorganic & Medicinal Chemistry Letters|December 21, 2012
The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer's diseaseHongmei Li, Jun Qin, Pawan Dhondi, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2008
Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonistsUnmesh Shah, Craig D Boyle, Samuel Chackalamannil, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2014
Quality by design (QbD) of amide isosteres: 5,5-Disubstituted isoxazolines as potent CRTh2 antagonists with favorable pharmacokinetic and drug-like propertiesDong Xiao, Xiaohong Zhu, Younong Yu, et al.
Pageof 7